Literature DB >> 1700749

Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.

M Deane1, J D Norton.   

Abstract

During B cell development, immunoglobulin heavy chain (IgH) variable region (VH) genes are rearranged and expressed in a programmed manner and accumulating evidence suggests recurrent utilization of developmentally restricted VH genes in malignant B lymphoid populations. We have used polymerase chain reaction gene amplification in conjunction with a panel of VH family-specific amplimers to directly compare the repertoire of VH region rearrangement in mature, CD5+ B cell chronic lymphocytic leukemia with that in immature, CD5 B lineage acute lymphoblastic leukemia. The results revealed a diverse pattern of VH family utilization common to both disease groups in which VH regions most proximal to the IgH joining locus were preferentially rearranged relative to their family sizes with recurrent utilization of several known developmentally restricted VH genes in close to germ-line configuration. These results indicate that biased VH family usage is independent of tumor cell phenotype in B lineage leukemias. This bias may reflect similar stages or compartments in normal B lymphopoiesis from which diverse types of B cell malignancy may arise. Moreover, since blast cells in acute lymphoblastic leukaemia do not express functional immunoglobulin, we infer that the tumor cell-associated VH family repertoire is determined through antigen-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700749     DOI: 10.1002/eji.1830201009

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

1.  Hodgkin's disease: immunoglobulin heavy and light chain gene rearrangements revealed in single Hodgkin/Reed-Sternberg cells.

Authors:  F Deng; G Lü; G Li; G Yang
Journal:  Mol Pathol       Date:  1999-02

2.  Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses.

Authors:  D H Margolin; K A Reimann; J Sodroski; G B Karlsson; K Tenner-Racz; P Racz; N L Letvin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Biologically-generated primer for PCR: PCR primer of unknown sequence.

Authors:  C Bindon; J Martindale; C Mitchell
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

4.  Assessment of IgH PCR strategies in multiple myeloma.

Authors:  R G Owen; R J Johnson; A C Rawstron; P A Evans; A Jack; G M Smith; J A Child; G J Morgan
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

5.  Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.

Authors:  A Matolcsy; P Casali; R G Nádor; Y F Liu; D M Knowles
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

6.  Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation.

Authors:  H Ikematsu; N Harindranath; Y Ueki; A L Notkins; P Casali
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

Review 7.  The polymerase chain reaction in diagnosing lymphoid disorders.

Authors:  K P McCarthy; D N Slack; J P Sloane
Journal:  Mol Biol Rep       Date:  1994-01       Impact factor: 2.316

8.  Molecular mechanisms resulting in pathogenic anti-mouse erythrocyte antibodies in New Zealand black mice.

Authors:  B B Scott; S Sadigh; M Stow; R A Mageed; E M Andrew; R N Maini
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

9.  Expansion of a B-lymphocyte clone producing IgM auto-antibodies encoded by a somatically mutated VHI gene in the spleen of an autoimmune patient.

Authors:  S Jahn; B Niemann; T Winkler; J R Kalden; R von Baehr
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

10.  Anti-mouse red blood cell monoclonal antibodies use functionally rearranged genes from the VH J558 family and are derived from the CD5- B-lymphocyte subpopulation.

Authors:  B B Scott; S Sadigh; M Stow; R A Mageed; E M Andrew; R N Maini
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.